GlassScriptPhysician profile
Rafael E Cordero
NPI 1629154620
$2,028.48
in general payments reported to CMS, 2019-2025
11 companies · $141 in 2025
The $141 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $854 · 2020: $162 · 2021: $192 · 2022: $279 · 2023: $169 · 2024: $232 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.01 |
| Education | $125.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohorizons Implant Systems INC. | $826.28 | 2019-2024 | Biohorizons |
| Zimvie INC. | $189.69 | 2023-2024 | |
| Zimmer Biomet Holdings, INC. | $189.37 | 2019 | |
| Dentsply Sirona INC | $171.77 | 2021-2022 | |
| Straumann USA LLC | $171.33 | 2019-2025 | |
| Southern Implants North America INC | $165.62 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $157.40 | 2019 | |
| Salvin Dental Specialties, INC. | $61.91 | 2019 | |
| Nobel Biocare USA | $39.77 | 2023 | Nobelactive |
| Dentsply Ih INC. | $39.47 | 2019 | |
| Zest Holdings, LLC | $15.87 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Cordero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.